Programmed Death 1 (PD-1) Expression in Relapsing and Remitting Hodgkin Lymphoma as Prognostic Factor

BACKGROUND: Programmed death ligand 1 (PD-L1) plays critical role in PD-1-dependent immunity suppress. Abnormal PD-L1 expression has shown to be directly related to poor prognosis and drug resistance in cancer patients. Hence, we aimed to evaluate PD-L1 expression in relapsing and remitting Hodgkin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouzari, Behnaz, Basi, Ali, Dadkhah, Shadi, Panahi, Mahshid, Mohammadi, Soha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685244/
https://www.ncbi.nlm.nih.gov/pubmed/37642071
http://dx.doi.org/10.31557/APJCP.2023.24.8.2829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685244/
https://www.ncbi.nlm.nih.gov/pubmed/37642071
http://dx.doi.org/10.31557/APJCP.2023.24.8.2829

Ejemplares similares